| Detected | Trial | Change |
|---|---|---|
| 2026-05-28 | NCT05972551 Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in… |
overall status: "Recruiting" → "Active Not Recruiting" |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06118905 | Preserving Geriatric Muscle With an Osteoporosis Medication | Osteoporosis | Recruiting |
| NCT05764733 | Bone, Exercise, Alendronate, and Caloric Restriction | Bone Loss | Recruiting |
| NCT05666310 | Muscle Impact of Treating Osteoporosis | Sarcopenia | Active, Not Recruiting |
| NCT05058976 | Romosozumab Use to Build Skeletal Integrity | Osteoporosis | Active, Not Recruiting |
| NCT04549207 | Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients… | Breast Cancer | Active, Not Recruiting |
| Phase 3 | |||
| NCT03295981 | Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone | Giant Cell Tumor of Bone | Recruiting |
| NCT06533865 | Romosozumab as an Adjunct to Physiologic Estrogen Replacement in Functional Hypothalamic… | FHA (Functional Hypothalamic Amenorrhea) | Recruiting |
| NCT05768854 | Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta | Osteogenesis Imperfecta | Active, Not Recruiting |
| NCT05972551 | Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in… | Osteogenesis Imperfecta | Active, Not Recruiting |
| Phase 2 | |||
| NCT04608630 | Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults | Critical Illness | Recruiting |
| NCT07043608 | Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases | Clear Cell Renal Cell Cancer (ccRCC) | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT06625190 | Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors | Neuroblastoma | Recruiting |
| NCT07471516 | Zoledronic Acid Treatment in Patients With Congenital Dyserythropoietic Anemia | Congenital Dyserythropoietic Anemia (CDA) | Recruiting |
| NCT06374459 | Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive… | Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer | Recruiting |
| Phase 1 | |||
| NCT07375290 | Zoledronate to Prevent Bone Health Complications in Pediatric Hematopoietic Stem Cell… | Hematopoietic Stem Cell Transplantation | Recruiting |
| Not specified | |||
| NCT03958565 | Response of Bony Metastasis to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers… | Carcinoma, Non-Small-Cell Lung | Recruiting |